Benchmarks after bowel resection in Crohn's disease: implementing clinically meaningful health-related quality of life targets
Related Experiment Video
Updated: Sep 14, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Thomas E Ueland1, Megan M Shroder2, Samuel A Younan2
1Vanderbilt University School of Medicine, Nashville, TN, USA.
Background:
Patient-reported outcome measure scores must be interpretable to be effective in a clinical setting. In this retrospective cohort study, we sought to establish the minimum clinically important difference (MCID) and patient acceptable symptom state (PASS) for health-related quality of life in Crohn's disease and to apply these thresholds to patients undergoing Crohn's-related bowel resection.
Methods:
Eligible participants were adults with Crohn's disease completing a patient-reported outcome measure and an additional anchor question about digestive satisfaction or change from a prior clinical visit. Multiple questionnaires were evaluated for alignment with digestive satisfaction, and the best-performing short inflammatory bowel disease questionnaire (sIBDQ) was retained for further analysis. Clinically meaningful threshold ranges were established for the sIBDQ through anchor- and distribution-based methodologies. These thresholds were applied to patients undergoing Crohn's-related bowel resection in three areas: rates of target score achievement at postoperative time points, factors associated with sIBDQ scores at final follow-up, and accessibility in the electronic medical record.
Results:
There were 492 and 228 responses included in the PASS and MCID analyses, respectively. For the sIBDQ, the PASS ranged from 51 to 63, while the MCID ranged from 6.5 to 9.5. In the 215 patients undergoing Crohn's-related bowel resection, the preoperative sIBDQ median (IQR) was 49 (30, 69) compared to postoperative scores of 56 (40, 73) at 1-12 months, 56 (39, 73) at 13-24 months, and 58 (42, 73) at more than 24 months. The PASS was achieved in 179 (84%) patients for at least one postoperative time point. Preoperative sIBDQ score and male sex were associated with higher quality of life at final follow-up.
Conclusion:
In Crohn's disease, clinically meaningful targets for quality of life may complement traditional metrics when monitoring progress after operative intervention.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome III: Medical and Nursing Management

